MetaCap

CollPlant Biotechnologies (CLGN) vs Lifeward (LFWD)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.

Summary

Lifeward is the larger company by market cap ($18.2 million vs $7.5 million), about 2.4 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Head-to-head

CLGN versus LFWD key metrics
MetricCLGNLFWD
Share price$3.97$6.43
Market cap$7.51M$18.21M
1-day change+14.74%-1.08%
YTD return—-6.12%
1-year return—-32.21%
5-year return—-94.31%
EPS (TTM)$-9.33$-15.73
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
52-week high$26.80$10.10
52-week low$2.64$4.14
Distance from 52-week high-85.19%-36.36%
Average volume351.98K6.15K
Shares outstanding1.89M2.83M
SectorHealth CareHealth Care
IndustryIndustrial SpecialtiesIndustrial Specialties

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • Lifeward is about 2.4 times larger than CollPlant Biotechnologies by market value ($18.21M vs $7.51M).

CLGN vs LFWD FAQ

Which is bigger, CollPlant Biotechnologies or Lifeward?

Lifeward (LFWD) is larger, with a market capitalization of $18.21M compared with $7.51M for CollPlant Biotechnologies (CLGN).

Are CollPlant Biotechnologies and Lifeward in the same industry?

Yes. Both are classified in the Industrial Specialties industry within the Health Care sector.

More comparisons